Barclays Maintains Underweight on Clorox, Raises Price Target to $137
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) but raises the price target from $130 to $137.
October 11, 2024 | 2:59 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox but raises the price target from $130 to $137.
The Underweight rating suggests a bearish outlook, but the raised price target indicates some positive expectations. The net impact is likely neutral in the short term as the mixed signals may balance each other out.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100